Table 1. Relationship between miR-202 expression and their clinic-pathological characteristics of endometrial cancer patients.
| Characteristics | Cases | miR-202 | P-value | |
|---|---|---|---|---|
| High | Low | |||
| Age (years) | 0.562 | |||
| ≥50 | 44 | 18 | 26 | |
| <50 | 32 | 10 | 22 | |
| Pathology classification | 0.063 | |||
| Well + Mod | 50 | 15 | 35 | |
| Poor | 26 | 13 | 13 | |
| FIGO stages | 0.021* | |||
| I + II | 54 | 20 | 34 | |
| III + IV | 22 | 8 | 14 | |
| Grade | 0.651 | |||
| G1 | 30 | 5 | 25 | |
| G2/3 | 46 | 23 | 23 | |
| Lymph node metastasis | 0.031* | |||
| Negative | 42 | 6 | 36 | |
| Positive | 34 | 22 | 12 | |
Statistical analyses were performed by the χ2 test.
*
P<0.05 was considered significant.